Nuwellis (NUWE) Appoints John Erb as CEO

Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to advancing solutions in fluid management, today announced the appointment of John Erb as its Chief Executive Officer. Erb, who has served as interim CEO since February 2025, will continue to lead the company with a focus on strategic clarity, operational discipline, and sustainable growth.

This marks Erb’s return to the CEO role at Nuwellis, having previously served in the position from 2015 – 2020. His reappointment reflects the Board’s confidence in his leadership and deep understanding of the company’s mission and potential. Under his interim leadership, Erb has brought stability and renewed momentum to the organization.

“I’m honored to lead Nuwellis at such a pivotal moment,” said John Erb, CEO of Nuwellis. “We have a passionate team, a therapy that saves lives, and a vision that resonates with clinicians. I’m excited to build on our strong foundation and drive the company forward.”

For more information about Nuwellis, please visit www.nuwellis.com.

You May Also Be Interested In

• Boeing names Ryan Shedd as new SVP and controller
• Silexion Therapeutics faces Nasdaq delisting over equity shortfall
• Hinge Health signs $86M office lease in San Francisco